# BMT CTN 0901 (NCT01339910)

> Reduced Intensity Regimen vs Myeloablative Regimen for Myeloid Leukemia or Myelodysplastic Syndrome (BMT CTN 0901)

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT01339910
- Phase: PHASE3
- Status: TERMINATED
- Sponsor: Medical College of Wisconsin
- Conditions: Leukemia, Myelocytic, Acute
- Interventions: Fludarabine and Busulfan; Fludarabine and Melphalan; Busulfan and Fludarabine; Busulfan and Cyclophosphamide; Cyclophosphamide and Total Body Irradiation
- Enrollment: 272
- Primary outcome: Percentage of Participants With Overall Survival (OS)

## Indexed commentary on BMT CTN 0901 so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 9
- Podcasts: 1

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=bmt-ctn-0901-nct01339910

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT01339910", "email": "<work email>"}; the inbox owner confirms by the emailed link.